GlassScriptPhysician profile
Farid Zehtab
NPI 1831155506
$29,856.59
in general payments reported to CMS, 2019-2025
13 companies · $2,562 in 2025
The $2,562 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $24.63 · 2021: $307 · 2022: $21K · 2023: $5,919 · 2024: $102 · 2025: $2,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Travel and Lodging: $2,276 · Food and Beverage: $1,291 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Travel and Lodging | $2,275.93 |
| Food and Beverage | $1,291.16 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,583.30 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,007.23 | 2022-2024 | Phasix Mesh |
| Stryker Corporation | $462.50 | 2019-2023 | 1688 |
| Allergan, INC. | $405.28 | 2019-2021 | |
| Medical Device Business Services, INC. | $128.60 | 2023 | Vistaseal |
| Ethicon US, LLC | $94.55 | 2021-2022 | |
| Medtronic, INC. | $42.97 | 2024-2025 | Progrip, Absorbatack |
| Baxter Healthcare | $28.24 | 2024 | Tisseel |
| Cook Medical LLC | $24.63 | 2020 | |
| Innocoll Pharmaceuticals Limited | $20.82 | 2022 | |
| Covidien LP | $20.18 | 2019 | |
| Teleflex LLC | $19.86 | 2025 | Quikclot |
| Tela Bio, INC. | $18.43 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Zehtab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.